Partage de l'actualité dans le domaine de la virologie médicale
21 Septembre 2023
/https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fwp-content%2Fuploads%2FHIV-cabotegravir-long-acting-tablets.jpg)
European Commission approves long-acting HIV drug option
The first long-acting injectable PrEP option proven superior to daily oral FTC/TDF in reducing HIV acquisition, has been approved in the EU.
/https%3A%2F%2Fvidalactus.vidal.fr%2Fpublic%2Fimages%2Factus%2FPrEP-TRUVADA-generiques-prescription-ville-tout-medecin-initiation-.jpg)
/http%3A%2F%2Fwww.sciencesetavenir.fr%2Fassets%2Fimg%2F2018%2F05%2F16%2Fcover-r4x3w1000-5afc5f7d6fcc0-transmissionvih.jpg%23width%3D1000%26height%3D747)
/http%3A%2F%2Fbeh.santepubliquefrance.fr%2Fbeh%2Fimages%2Fsante-publique-header.png%23width%3D106%26height%3D60)
/http%3A%2F%2Fvih.org%2Fwp-content%2Fuploads%2F2019%2F10%2Fdecouvertes2019-2.png%23width%3D1250%26height%3D404)